Krónikus obstruktív tüdőbetegség (COPD): vizsgálatok itt: Magyarország
12 of 15 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleeValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- Where
- Hajdunanas, Mosonmagyaróvár, Pécs
- Életkor
- 40 év to 75 év
- People
- 1196 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07177339 · EU 2025-521108-23-00 - 3. fázisTaking peopleEfficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Where
- Debrecen, Edelény, Gödöllő, Gyöngyös, Hajdúnánás, Mosonmagyaróvár, Pécs, Püspökladány, Szolnok, Tapolca
- Életkor
- 40 év to 80 év
- People
- 942 worldwide
- Run by
- Sanofi
See details and how to joinNCT07190209 · EU 2024-518016-39-00 - 2. fázisTaking peopleA study to investigate the effect of AZD6793 in participants with moderate to very severe chronic obstructive pulmonary disease
- Where
- Balassagyarmat, Budapest, Debrecen, Gödöllő, Hajdúnánás, Pécs, Szombathely, Törökbálint
- Életkor
- 18 év and over
- People
- 307 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-520473-40-00 - 2. fázisTaking peopleA Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Where
- Budapest XIV, Budapest XX, Edelény, Gödöllő, Pécs
- Életkor
- 40 év to 75 év
- People
- 606 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07759245 · EU 2026-525480-41-00 - 2. fázisTaking peopleA Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Where
- Balassagyarmat, Budapest, Debrecen, Edelény, Encs, Gödöllő, Hajdúnánás, Nyíregyháza-Sóstóhegy, Pécs, Szombathely, Törökbálint
- Életkor
- 40 év and over
- People
- 987 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07082738 - 2/3. fázisTaking peopleA Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Where
- Edelény, Gödöllő, Hajdúnánás, Mosonmagyaróvár, Pecs
- Életkor
- 35 év to 80 év
- People
- 1156 worldwide
- Run by
- Pfizer
See details and how to joinNCT07363694 · EU 2024-518587-12-00 - 4. fázisTaking peopleA Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- Where
- Debrecen, Hajdúnánás, Pécs
- Életkor
- 40 év to 85 év
- People
- 218 worldwide
- Run by
- Sanofi
See details and how to joinNCT07053423 - 3. fázisTaking peopleA Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Where
- Budapest III, Debrecen, Edelény, Gödöllő, Hatvan, Mosonmagyaróvár, Nyiregyhaza, Törökbálint
- Életkor
- 40 év to 80 év
- People
- 990 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06878261 · EU 2024-517457-27-00 - 2. fázisNot yet taking people in MagyarországA Randomized, Double-Blind, Placebo-controlled, Parallel Arm, 52-week Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of Two Doses of EXPD-101 in Participants with COPD
- Where
- Budapest Viii, Gödöllő, Mosonmagyaróvár, Pécs
- Életkor
- 18 év and over
- People
- 183 worldwide
- Run by
- Expedition Therapeutics Inc.
See details and how to join2026-525216-34-00 - 3. fázisTaking peopleDepemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
- Where
- Budapest, Debrecen, Gyula, Hajdunanas, Pécs, Törökbálint
- Életkor
- 40 év to 80 év
- People
- 981 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06959095 · EU 2024-520418-22-00 - 3. fázisFut, nem toborozA Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Where
- Balatonfüred, Budapest, Budapest III, Budapest XII, Budapest XIX, Debrecen, Edelény, Encs, Gödöllő, Gyöngyös, Hajdunanas, Kalocsa, Komadi, Monor, Nyiregyhaza, Pecs, Puspokladany, Szazhalombatta, Szeged, Székesfehérvár, Szolnok, Tapolca, Törökbálint, Vajszlo
- Életkor
- 40 év to 80 év
- People
- 5250 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06283966 · EU 2023-507407-59-00 - 4. fázisNot yet taking people in MagyarországThe effect of Broncho-Vaxom on the COPD exacerbations in terms of lung function, lung mechanics, immune state, body composition, quality of life and physical activity.
- Where
- Budapest VIII, Pécs
- Életkor
- 18 év and over
- People
- 260
- Run by
- Semmelweis University
See details and how to join2025-524501-32-02